not yet recruiting

MPS II Immunophenotyping

key information

study id #: NCT04976231

condition: MPS II, Mucopolysaccharidosis II, Hunter Syndrome

status: Not yet recruiting


The purpose of this study is to investigate how participant’s body’s immune system responds to idursulfase, an enzyme replacement therapy (ERT) and find out which types of immune cells are involved in causing untoward responses to the ERT so that the investigators can relate the level of immune response to the treatment.


last updated: February 26, 2022